Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synbiotic as Adjuvant Therapy in Parkinson's Disease
NCT05576818Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Jun 2022
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Parkinson's disease (PD) (2 arms), sponsored by Tanta University. Primary endpoint: Change in MDS-Unified Parkinson's Disease Rating Scale at 3 months. Started Jun 2022; status: recruiting.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05576818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05576818.